The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes

Author(s):  
Lilianne Abramsson-Zetterberg ◽  
Louise J.K. Durling ◽  
Fan Yang-Wallentin ◽  
Elisabet Rytter ◽  
Bengt Vessby
PLoS ONE ◽  
2017 ◽  
Vol 12 (11) ◽  
pp. e0187090 ◽  
Author(s):  
Tanvir Abir ◽  
Felix Akpojene Ogbo ◽  
Garry John Stevens ◽  
Andrew Nicolas Page ◽  
Abul Hasnat Milton ◽  
...  

2011 ◽  
Vol 31 (4) ◽  
pp. 500-506 ◽  
Author(s):  
Amy J. Hewitt ◽  
Amber L. Knuff ◽  
Matthew J. Jefkins ◽  
Christine P. Collier ◽  
James N. Reynolds ◽  
...  

2021 ◽  
pp. 1-25
Author(s):  
Lucía Iglesias-Vázquez ◽  
Núria Serrat ◽  
Cristina Bedmar ◽  
Meritxell Pallejà-Millán ◽  
Victoria Arija

Abstract This research evaluates the prevalence of inadequate folate status in early pregnancy, the pattern of prenatal folic acid (FA) supplementation and associated factors in Spanish pregnant women from the ECLIPSES study, which included 791 participants prior gestational week 12. A cross-sectional evaluation of red blood cell (RBC) folate levels was performed at recruitment and used to calculate the prevalence of folate deficiency (RBC folate<340 nmol/L) and insufficiency (RBC folate<906 nmol/L). Sociodemographic and lifestyle data, as well as information on prenatal FA supplementation were recorded. Descriptive and multivariate statistical analyses were performed. The prevalence of folate deficiency and insufficiency were 9.6% and 86.5%, respectively. Most of women used prenatal FA supplements but only 6.3% did so as recommended. Supplementation with FA during the periconceptional period abolished folate deficiency and reduced folate insufficiency. Prenatal folic acid supplementation with ≥1000 µg/d in periconceptional time and pregnancy planning increased RBC folate levels. The main risk factor for folate insufficiency in early pregnancy were getting prenatal FA supplementation out of the periconceptional time (OR 3.32, 95%CI 1.02–15.36), while for folate deficiency they were young age (OR 2.02, 95%CI 1.05–3.99), and smoking (OR 2.39, 95%CI 1.30–4.37). In addition, social and ethnic differences according to folate status were also identified. As conclusion, periconceptional FA use is crucial for achieving optimal folate levels in early pregnancy. Pregnancy planning should focus on young women, smokers, those with low consumption of folate-rich foods, low socioeconomic status or from ethnic minorities.


2013 ◽  
Vol 27 (S1) ◽  
Author(s):  
Ligi Paul ◽  
Cristina Razzari ◽  
Francesca Sampietro ◽  
Gessica Fontana ◽  
Isabella Fermo ◽  
...  

2008 ◽  
Vol 88 (3) ◽  
pp. 489-497 ◽  
Author(s):  
H. Méthot ◽  
C. L. Girard ◽  
J. J. Matte ◽  
F. W. Castonguay

The objective of this project was to assess the impact of periconceptional folic acid supplementation on the reproductive performance of prolific and non-prolific ewes, in the estrous and anestrous seasons. Two initial trials took place during the estrous season at two experimental sites where 38 Dorset and 39 half-Finn half-Dorset ewes (site A) as well as 80 Dorset ewes (site C) were divided into two groups receiving either 0 or 210 mg ewe-1 d-1 of folic acid over a period which extended from 21 d premating to 30 d postmating. Three other trials were conducted in the anestrous season where 80 Dorset ewes (site A), 56 half-Romanov ewes (site B) and 78 Dorset ewes (site C) were subjected to the same protocol as the one used in the breeding season. In all the trials, the folic acid supplement increased plasma and red cell folates, but had no effect on fertility, embryonic mortality, or the size or weight of the litter at birth. Folic acid supplementation did not improve the reproductive performance of prolific and non-prolific ewes, either in the estrous season or in the anestrous period. Key words: Ewes, reproduction, vitamins, folic acid, fertility, prolificacy


2005 ◽  
Vol 51 (3) ◽  
pp. 629-634 ◽  
Author(s):  
Valerie A Holmes ◽  
Julie MW Wallace ◽  
H Denis Alexander ◽  
William S Gilmore ◽  
Ian Bradbury ◽  
...  

Abstract Background: In many countries, current recommendations are that women take a daily 400-μg folic acid supplement from before conception until the end of the 12th week of gestation for the prevention of neural tube defects. Low folate status is associated with an increased concentration of plasma total homocysteine (tHcy), a risk factor associated with pregnancy complications such as preeclampsia. Methods: In a longitudinal study, we determined tHcy and corresponding folate status in 101 pregnant women at 12, 20, and 35 weeks of gestation, in 35 nonpregnant controls sampled concurrently, and in a subgroup (n = 21 pregnant women and 19 nonpregnant controls) at 3 days postpartum. Results: Plasma tHcy was significantly lower throughout pregnancy compared with nonpregnant controls, with values lowest in the second trimester before increasing toward nonpregnant values in the third trimester. Importantly, mean tHcy concentrations were lower in pregnant women taking folic acid supplements than in those not, an effect that reached significance in the third trimester (5.45 vs 7.40 μmol/L; P &lt;0.05). During the third trimester, tHcy concentrations were significantly higher in pregnant women with a history of miscarriage than in women with no previous history (8.15 vs 6.38 μmol/L; P &lt;0.01). Conclusions: This is the first longitudinal study to show that homocysteine concentrations increase in late pregnancy toward nonpregnant values; an increase that can be limited by enhancing folate status through continued folic acid supplementation. These results indicate a potential role for continued folic acid supplementation in reducing pregnancy complications associated with hyperhomocysteinemia.


2005 ◽  
Vol 94 (4) ◽  
pp. 602-608 ◽  
Author(s):  
Emma Williams ◽  
Barbara Stewart-Knox ◽  
Ian Bradbury ◽  
Ian Rowland ◽  
Kristina Pentieva ◽  
...  

Evidence suggests that low folate status may be detrimental to mood and associated with depleted cerebrospinal fluid levels of the neurotransmitter serotonin (5-hydroxytryptamine; 5-HT). A placebo-controlled trial was carried out to determine the effect of folic acid supplementation (100 μg for 6 weeks followed by 200 μg for a further 6 weeks) upon subjective mood (Positive and Negative Affect Schedule) and biochemical markers of mood (5-HT) in healthy males (n23). Blood samples were obtained at baseline (week 0) and during the intervention at week 6 and week 12. Subjective mood assessments were obtained at week 0 and week 12. The results showed an increase in serum and erythrocyte folate concentrations (P=0·02 andP=0·003, respectively) and a corresponding decrease in plasma homocysteine (P=0·015) in response to the folic acid intervention. Neither subjective mood nor 5-HT levels, however, were significantly altered in response to the change in folate status. Folic acid given at physiological doses did not appear to improve the mood of healthy folate-replete individuals over a 12-week period. Further research is needed to address the effect of folic acid supplementation or of longer duration or increased dose, particularly in the face of sub-optimal folate status.


Sign in / Sign up

Export Citation Format

Share Document